Perrigo Company Announces FDA Approval For Simvastatin Tablets

Sat, 23 Dec 2006 02:00 PM EST

... The Perrigo Company (Nasdaq: PRGO; TASE) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market Simvastatin Tablets, USP, 5 mg, 10 mg, 20 mg, 40 mg and 80 mg. Perrigo's partner, Bentley Pharmaceuticals, Inc. is manufacturing the product at their Belmac Laboratories facility located in Zaragoza, Spain. Shipments will begin immediately. [click link for full article] ...